Abstract Objective This study assesses the 3‐month effectiveness of the calcitonin gene‐related peptide monoclonal antibody galcanezumab versus traditional oral migraine preventive medications. Background Studies comparing the effectiveness of calcitonin gene‐related peptide monoclonal antibodies versus traditional oral migraine preventive medications ...
Richard B. Lipton +7 more
wiley +1 more source
Endogenous treatments for migraine pain. [PDF]
Della Pietra A, Russo AF.
europepmc +1 more source
Cortical network dysfunction in migraine: linking genes, metabolism and clinical disability. [PDF]
Kuang L +13 more
europepmc +1 more source
NON-MIGRAINE RELATED PAIN BEHAVIOURS IN A TRANSGENIC "MIGRAINE MOUSE" WITH CIRCADIAN DISRUPTION [PDF]
Goadsby, Peter J +6 more
core +1 more source
Discomfort and Reading Speed: Effects of Migraine
Sarah M. Haigh, Isabella M Durda
openalex +1 more source
Migraine and pregnancy-related headaches as a risk factor for cardiovascular and cerebrovascular events in pregnancy: a systematic review and meta-analysis of over 94 million pregnancies. [PDF]
Mohamed MI +5 more
europepmc +1 more source
Real-world effectiveness of eptinezumab in chronic migraine-increase in good days in three subgroups: psychiatric comorbidities, prior subcutaneous anti-calcitonin gene-related peptide therapy, and migraine-associated brain fog. [PDF]
Argoff C +9 more
europepmc +1 more source
Impaired meningeal lymphatic drainage correlates with headache intensity in episodic migraine. [PDF]
Ren X +9 more
europepmc +1 more source
Analysis and comparison of the trends in the burden of migraine in China and globally from 1990 to 2021, with a forecast to 2031. [PDF]
Tang W +5 more
europepmc +1 more source

